Acceleron Pharma reported $45.11M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 2.98B 99M
Acceleron Pharma XLRN:US $ 45.11M 9.64M
Akebia Therapeutics AKBA:US $ 46.36M 4.71M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Amgen AMGN:US $ 1.31B 79M
Arena Pharmaceuticals ARNA:US $ 30.3M 1.63M
Bayer BAYN:GR 3.77B 19M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Bluebird Bio BLUE:US $ 68.28M 10.3M
Clovis Oncology CLVS:US $ 32.2M 722K
Dicerna Pharmaceuticals DRNA:US $ 21.99M 3.47M
Eli Lilly And LLY:US $ 1.58B 107.8M
Exelixis EXEL:US $ 101.56M 3.06M
Gilead Sciences GILD:US $ 1.18B 173M
GlaxoSmithKline GSK:LN 2.5B 6M
Johnson & Johnson JNJ:US $ 6B 73M
Karyopharm Therapeutics KPTI:US $ 35.1M 1.43M
Mirati Therapeutics MRTX:US $ 35.18M 5.57M
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Novartis NOVN:VX 3.6B 109M
Pfizer PFE:US $ 2.73B 61M
Ptc Therapeutics PTCT:US $ 69.25M 374K
Puma Biotechnology PBYI:US $ 26.08M 13.33M
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Rigel Pharmaceuticals RIGL:US $ 22.88M 499K
Sangamo Biosciences SGMO:US $ 14.5M 1.98M
Tg Therapeutics TGTX:US $ 34.9M 882K
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
United Therapeutics UTHR:US $ 109.1M 3.7M
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M